FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAlign Technology, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALGN
Align Technology, Inc. Stock AnalysisComprehensive stock analysis for Align Technology, Inc. (ALGN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisALGN
ALGN
Align Technology, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALGN
  1. Home
  2. Stocks
  3. Align Technology, Inc.

Align Technology, Inc.

🇺🇸ALGN•NASDAQ

Align Technology, Inc.

🇺🇸ALGN•NASDAQ
Market cap
$11.70B
Sentiment

Your view on ALGN

Mkt Cap
$11.70B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Align Technology, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Joseph M. Hogan
Headquarters
410 North Scottsdale Road, Tempe, AZ, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Joseph M. Hogan
Headquarters
410 North Scottsdale Road, Tempe, AZ, US
Description

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth.

This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment.

The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers.

This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan.

The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Align Technology, Inc. from FRC's valuation model, read against the market price. ALGN last traded at $165.98, 24.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Align Technology, Inc.. Starting points for Align Technology, Inc.: P/E 24.2, EPS $6.93, beta 1.74 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Align Technology, Inc.. Align Technology, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Align Technology, Inc.. Trailing twelve-month EPS for Align Technology, Inc. stands at $6.93. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$194.17

average of 12 firms, last 12 months

 

$194.17

Low $162.00

Median $200.00

High $215.00

 

Analyst Ratings

Buy11 firms, last 12 months
  • Strong Buy0
  • Buy7
  • Hold4
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$3.06$2.71$11.12$12.28
Low estimate$3.03$2.64$11.03$11.95
High estimate$3.09$2.89$11.33$12.76
No. of analysts971010
Year-ago EPS$3.29$2.58$5.65—
Growth-6.9%+5.1%+96.9%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$1.01B$1.04B$4.13B$4.24B
Low estimate$998.10M$1.01B$4.12B$4.11B
High estimate$1.02B$1.07B$4.20B$4.32B
No. of analysts751212
Year-ago revenue$1.05B$1.04B$4.03B—
Growth-3.2%+0.2%+2.2%—
Recent analyst actions15 rating and price-target changes, latest Oct 29, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Align Technology, Inc.. Align Technology, Inc. has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ALGN16 companies · 8 funds
Compare ALGN with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • MLSSMilestone Scientific Inc.Medical - Instruments & Supplies$27M
  • NVSTEnvista Holdings CorpMedical - Instruments & Supplies$3.9B
  • SAUHYStraumann Holding AGMedical - Instruments & Supplies$19.1B
  • XRAYDENTSPLY SIRONA Inc.Medical - Instruments & Supplies$1.8B

More Medical - Devices companies

  • SENSSenseonics Holdings, Inc.NASDAQ$597M
  • SGHTSight Sciences, Inc.NASDAQ$589M
  • SHOMSouthern Home Medical, Inc.OTC$398,670
  • SIBNSI-BONE, Inc.NASDAQ$1.1B
  • SINTSintx Technologies, Inc.NASDAQ$10M
  • SMMNYSiemens Healthineers AGPNK$110.6B
  • SNNSmith & Nephew plcNYSE$13.0B
  • SNNUFSmith & Nephew plcOTC$15.3B
  • SNWVSANUWAVE Health, Inc.NASDAQ$16M
  • SNZZFSenzime AB (publ)OTC$84M
  • SOM.AXSomnoMed LimitedASX
  • SOMNFSomnoMed LimitedOTC$111M

ETFs holding Align Technology, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.02%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.01%
  • VBVanguard Small-Cap ETF$76.9B in assets0.13%
  • RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.21%
  • CGMMCapital Group U.S. Small and Mid Cap ETF$3.6B in assets1.62%
  • BAFEBrown Advisory Flexible Equity ETF$1.7B in assets1.54%
  • FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets1.45%
  • SMOTVanEck Morningstar SMID Moat ETF$327M in assets1.29%

Largest holders first, then the funds most concentrated in ALGN.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Align Technology, Inc., and how their positions are changing. At a $11.70B market value, institutional positions materially move Align Technology, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Align Technology, Inc. executives and directors. Shares of Align Technology, Inc. have traded between $122.00 and $246.19 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Align Technology, Inc.. Align Technology, Inc. is a $11.70B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Align Technology, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Align Technology, Inc.. Coverage tracks Align Technology, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Align Technology, Inc.

ALGN Analysis
Fair
Past4
Growth3
Health5
Profit1
Value1

News

Latest Market News